Medigene AG
MDGEFOTCHealthcare● Active
$2.59
+$0.00(+0.00%)
Market Cap$38170366
P/E Ratio—
52W High$2.59
52W Low$0.1
Medigene AG（MDGEF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDGEF · 截至 2026-06-16
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($16.18M) | ($8.33M) | ($9.98M) | ($28.88M) | ($19.96M) |
| Depreciation & Amort. | $1.46M | $21.85M | $3.43M | $6.47M | $2.37M |
| Stock-Based Comp. | $0.31M | $0.35M | $0.65M | $0.66M | $0.49M |
| Change in Working Capital | ($0.00M) | ($0.89M) | ($4.68M) | ($2.86M) | $1.46M |
| Net Cash from Operations | ($15.12M) | $11.98M | ($10.75M) | ($24.79M) | ($16.42M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.66M) | ($1.01M) | ($0.13M) | ($0.48M) | ($1.43M) |
| Purchases of Investments | ($3.05M) | ($11.00M) | ($4.15M) | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $11.05M | $4.12M | $20.58M | $24.59M |
| Net Cash from Investing | $2.38M | ($12.01M) | $4.03M | $21.12M | $24.17M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.17M) | ($0.17M) | ($0.19M) | ($0.28M) | ($1.25M) |
| Net Cash from Financing | ($0.78M) | ($0.28M) | ($1.03M) | ($0.83M) | ($0.47M) |
| Free Cash Flow | |||||
| Free Cash Flow | ($15.78M) | $10.97M | ($10.88M) | ($25.27M) | ($17.85M) |
| FCF Margin %(computed) | -261.57% | 35.10% | -103.98% | -315.80% | -169.83% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-16 · EUR · M
深入了解Medigene AG
关于Medigene AG（MDGEF）现金流量表
Medigene AG 2023财年经营活动现金流($0.02B)，自由现金流($0.02B)（FCF利润率-261.57%），资本支出($0.00B)。
常见问题
MDGEF · 4 问Medigene AG 2023财年自由现金流($0.02B)，同比down243.9%。
MDGEF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-16